Abstract: The present invention is a wheelchair handle system we are by a pivot bracket supports an adjustable handle and the pivot bracket is configured to be attached and secured to an existing wheelchair arm.

Abstract: Use of interferon-beta (IFN-?) and/or IFN-? for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have a clinical history of recurrent RV infections, and may have other medical conditions, such as cardiac or circulation problems, and who are liable to suffer severe complications/high mortality from poor innate ability to fight such a viral infection.

Abstract: The present invention relates to use of epidermal growth factor (EGF) analogues to treat, or protect from, bronchial epithelium damage in asthma patients. Suitable such analogues target the EGF receptor and exhibit ability to promote in asthma patients preferential proliferation of bronchial epithelial cells compared to airway fibroblasts.

Abstract: The present invention provides the use of IFN-?, an agent that increases the expression of IFN-?, or a polynucleotide which is capable of expressing IFN-? or said agent for the manufacture of a medicament for the treatment of rhinovirus-induced exacerbation of a respiratory disease selected from asthma and chronic obstructive pulmonary disease, wherein said treatment is by airway delivery of said medicament, e.g. by use of an aerosol nebuliser. Also provided is IFN-? for the same purpose.

Abstract: The present invention relates to the use of an air-liquid interface culture model using asthmatic bronchial epithelial cells, which exhibit impaired epithelial barrier function. It is proposed to use asthmatic epithelial cultures, in the absence of added Th2 or proinflammatory cytokines such as IL-13, as an in vitro model to screen for agents that can act to improve impaired asthmatic epithelial barrier function. Such agents may have therapeutic utility in asthma patients.

Abstract: A method of selecting polyethylene components for a polyethylene composition having an improved Vicat softening point comprising blending at least a first polyethylene having a first density and a second polyethylene having a second density to form the polyethylene composition, wherein the first density is greater than the second density, and determining a first Vicat softening point (V1) of the composition measured, and calculating a second Vicat softening point (V2) of the composition using the formula V2=[?1n{W1(Vicat softening point of the first polyethylene)+W2(Vicat softening point of the second polyethylene) . . . Wn(Vicat softening point of the nth polyethylene)}], wherein W1 is the weight fraction of the first polyethylene, W2 is the weight fraction of the second polyethylene and Wn is the weight fraction of the nth polyethylene, n ranges from 2 to 10 and W1+W2 . . . +Wn=1.0; comparing V1 and V2; selecting the polyethylene components such that V1 is less than V2 for the polyethylene composition.

Abstract: The invention relates to a film structure combining a metallocene-rich layer and an HDPE-containing layer. A preferred embodiment is a structure having metallocene-rich skin layers and an HDPE-containing core. The structures of the invention are particularly useful for collation shrink.

Abstract: The invention concerns the use of fatty acid amides as antiblock additives for film-forming compositions, eliminating the necessity of inorganic additives.

Abstract: The invention relates to a film structure combining a metallocene-rich layer and an HDPE-containing layer. A preferred embodiment is a structure having metallocene-rich skin layers and an HDPE-containing core. The structures of the invention are particularly useful for collation shrink.